체외수정(IVF) 시장 규모, 점유율, 예측 및 동향 분석 : 유형별, 제품별, 주기별, 용도별, 최종 사용자별 - 세계 예측(-2031년)

The In Vitro Fertilization (IVF) market is projected to reach $4.20 billion by 2031 at a CAGR of 7.1% from 2024 to 2031.

After extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges. The growth of the IVF market is primarily driven by increasing infertility rates, technological advancements in IVF procedures, the high success rates of pregnancy through IVF, changing socio-cultural norms, favorable government regulations & policies, and the reducing costs of IVF. However, the health risks & complications associated with IVF treatment, such as ovarian hyperstimulation syndrome and multiple pregnancies, and the risk of unsuccessful cycles restrain the growth of this market.

Furthermore, the increasing access to Preimplantation Genetic Testing (PGT) for selecting the best embryos is expected to offer growth opportunities for the players operating in the IVF market. However, the limited availability of specialized IVF clinics, especially in rural areas, and the risk of birth defects in babies born through IVF are major challenges in the IVF market. Additionally, elective egg freezing, elective single-embryo transfers, and the integration of AI in IVF treatment are prominent trends in the IVF market.

The report offers a competitive landscape based on an extensive assessment of the leading players' product portfolios, geographic presence, and key strategies adopted over the last four years (2020-2024). The key players operating in the in vitro fertilization market are Esco Micro Pte. Ltd. (Singapore), Vitrolife Sweden AB (Sweden), Thermo Fisher Scientific Inc. (U.S.), Rocket Medical plc (U.K.), Kitazato Corporation (Japan), CooperSurgical, Inc. (U.S.), FUJIFILM Irvine Scientific. (U.S.), Hamilton Thorne Inc. (U.S.), Carl Zeiss AG (Germany), FERTIPRO NV (Belgium), and The Baker Company (U.S.).

Among all the products studied in this report, in 2024, the instruments segment is expected to account for the largest share of 62.9% of the in vitro fertilization market. The instruments segment is further categorized into imaging systems, ovum aspiration pumps, micromanipulator systems, gas analyzers, incubators, laser analyzers, cryosystems, sperm separation devices, sperm analyzer systems, sterile cabinets, and other instruments. The rising demand for advanced IVF instruments, high affordability in the private sector, the increasing number of fertility clinics, and rising healthcare expenditures support the segment's large market share.

Among all the applications studied in this report, in 2024, the human reproduction segment is expected to account for the major share of the in vitro fertilization market. The segment's large share is attributed to the increasing demand for IVF due to increasing pregnancy success rates through IVF, rising healthcare expenditures, the increasing demand for IVF due to changing socio-demographic trends, the availability of modern technologies, and decreasing natural fertility rates. For instance, according to the World Health Organization's April 2023 Report, 1 in 6 people globally are affected by infertility.

Based on end user, the IVF market is segmented into hospitals, fertility clinics, research institutes, and cryobanks. In 2024, the fertility clinics segment is expected to account for the largest share of the in vitro fertilization market. The large share of this segment is attributed to the increased adoption of advanced techniques in fertility clinics for the treatment of infertility. Additionally, fertility clinics have specialized expertise and also offer a comprehensive range of services beyond IVF, including counseling and egg freezing. The rising demand for IVF treatments and the increasing number of IVF clinics worldwide are further supporting the segment's large share. For instance, according to the National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health (U.S.), there are approximately 500 fertility clinics in the U.S.

An in-depth analysis of the geographical scenario of the global IVF market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of 42.0% of the in vitro fertilization market. North America's large market share is attributed to the availability of advanced infrastructure, high healthcare expenditures, favorable policies, and the presence of key players with well-established distribution channels in the region. However, Asia-Pacific is expected to register the highest CAGR of 9.4% during the forecast period due to the growing number of individuals with infertility, changing socio-cultural norms, increasing healthcare expenditures, and increasing access to fertility clinics in the region.

Scope of the Report:

In Vitro Fertilization Market Assessment-by Product

• Instruments
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Gas Analyzers
  • Incubators
  • Laser Analyzers
  • Cryosystems
  • Sperm Separation Devices
  • Sperm Analyzer Systems
  • Sterile Cabinets
  • Other Instruments

Note: Other Instruments include anti-vibration tables, air purification systems, witness systems, glass heaters, and tube warmers.

• Reagents & Media
  • IVM Medium & IVF Media
  • Sperm & Ovum Processing Media
  • Verification Media
  • Cryopreservation Media
  • Staining Kits & QC Beads
• Accessories
  • Catheters & Cannulas
  • Needles
  • Micromanipulation Pipettes
  • Other Accessories

Note: Other accessories include dishes, pipettes, tubes, sperm-counting chambers, shelves, and microscope slides.

In Vitro Fertilization Market Assessment-by Type

• Natural IVF
• Minimal Stimulation IVF
• In Vitro Maturation
• Intracytoplasmic Sperm Injection
• Other Types

Note: Other types include needle-free IVF, ovarian rejuvenation therapy, and egg freezing.

In Vitro Fertilization Market Assessment-by Cycle

• Frozen Non-donor IVF Cycles
• Fresh Non-donor IVF Cycles
• Fresh Donor IVF Cycles
• Frozen Donor IVF Cycles

In Vitro Fertilization Market Assessment-by Application

• Human Reproduction
• Research & Reproductive Toxicology

In Vitro Fertilization Market Assessment-by End User

• Hospitals
• Fertility Clinics
• Research Institutes
• Cryobanks

In Vitro Fertilization Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Finland
  • Austria
  • Switzerland
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATAM)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Data Collection & Validation Process
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing & Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Increasing Infertility Rates
  • 4.2.2. Technological Advancements in IVF Procedures
  • 4.2.3. High Success Rates of Pregnancy Through IVF
  • 4.2.4. Changing Socio-cultural Norms
  • 4.2.5. Favorable Government Regulations & Policies
  • 4.2.6. Reducing Costs of IVF
• 4.3. Restraints
  • 4.3.1. Health Risks & Complications Associated with IVF Treatments
  • 4.3.2. Risk of Unsuccessful Cycle
• 4.4. Opportunities
  • 4.4.1. Increasing Access to Preimplantation Genetic Testing (PGT) for Selecting the Best Embryos
• 4.5. Challenges
  • 4.5.1. Limited Availability of Specialized IVF Clinics in Rural Areas
  • 4.5.2. Risk of Birth Defects Among Babies Born Through IVF
• 4.6. Trends
  • 4.6.1. Elective Egg Freezing
  • 4.6.2. Elective Single-embryo Transfers
  • 4.6.3. Integration of AI into IVF Treatments
• 4.7. Factor Analysis
• 4.8. Regulatory Analysis
• 4.9. Pricing Analysis
• 4.10. Porter's Five Force Analysis

5. In Vitro Fertilization Market Assessment-by Product

• 5.1. Overview
• 5.2. Instruments
  • 5.2.1. Imaging Systems
  • 5.2.2. Ovum Aspiration Pumps
  • 5.2.3. Micromanipulator Systems
  • 5.2.4. Gas Analyzers
  • 5.2.5. Incubators
  • 5.2.6. Laser Analyzers
  • 5.2.7. Cryosystems
  • 5.2.8. Sperm Separation Devices
  • 5.2.9. Sperm Analyzer Systems
  • 5.2.10. Sterile Cabinets
  • 5.2.11. Other Instruments
• 5.3. Reagents & Media
  • 5.3.1. IVM Medium & IVF Media
  • 5.3.2. Sperm & Ovum Processing Media
  • 5.3.3. Verification Media
  • 5.3.4. Cryopreservation Media
  • 5.3.5. Staining Kits & QC Beads
• 5.4. Accessories
  • 5.4.1. Catheters & Cannulas
  • 5.4.2. Needles
  • 5.4.3. Micromanipulation Pipettes
  • 5.4.4. Other Accessories

6. In Vitro Fertilization Market Assessment-by Type

• 6.1. Overview
• 6.2. Natural IVF
• 6.3. Minimal Stimulation IVF
• 6.4. In Vitro Maturation
• 6.5. Intracytoplasmic Sperm Injection
• 6.6. Other Types

7. In Vitro Fertilization Market Assessment-by Cycle

• 7.1. Overview
• 7.2. Frozen Non-donor IVF Cycles
• 7.3. Fresh Non-donor IVF Cycles
• 7.4. Fresh Donor IVF Cycles
• 7.5. Frozen Donor IVF Cycles

8. In Vitro Fertilization Market Assessment-by Application

• 8.1. Overview
• 8.2. Human Reproduction
• 8.3. Research & Reproductive Toxicology

9. In Vitro Fertilization Market Assessment-by End User

• 9.1. Overview
• 9.2. Hospitals
• 9.3. Fertility Clinics
• 9.4. Research Institutes
• 9.5. Cryobanks

10. In Vitro Fertilization Market Assessment-by Geography

• 10.1. Overview
• 10.2. North America
  • 10.2.1. U.S.
  • 10.2.2. Canada
• 10.3. Europe
  • 10.3.1. Germany
  • 10.3.2. France
  • 10.3.3. U.K.
  • 10.3.4. Italy
  • 10.3.5. Spain
  • 10.3.6. Finland
  • 10.3.7. Austria
  • 10.3.8. Switzerland
  • 10.3.9. Rest of Europe (RoE)
• 10.4. Asia-Pacific
  • 10.4.1. Japan
  • 10.4.2. China
  • 10.4.3. India
  • 10.4.4. South Korea
  • 10.4.5. Australia
  • 10.4.6. Rest of Asia-Pacific (RoAPAC)
• 10.5. Latin America
  • 10.5.1. Brazil
  • 10.5.2. Mexico
  • 10.5.3. Rest of Latin America (RoLATAM)
• 10.6. Middle East & Africa

11. Competition Analysis

• 11.1. Overview
• 11.2. Key Growth Strategies
• 11.3. Competitive Benchmarking
• 11.4. Competitive Dashboard
  • 11.4.1. Industry Leaders
  • 11.4.2. Market Differentiators
  • 11.4.3. Vanguards
  • 11.4.4. Emerging Companies
• 11.5. Market Share Analysis/Market Rankings of Key Players (2023)

12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

• 12.1. Esco Micro Pte. Ltd.
• 12.2. Vitrolife Sweden AB
• 12.3. Thermo Fisher Scientific Inc.
• 12.4. Rocket Medical plc
• 12.5. Kitazato Corporation
• 12.6. CooperSurgical, Inc.
• 12.7. FUJIFILM Irvine Scientific.
• 12.8. Hamilton Thorne Inc.
• 12.9. Carl Zeiss AG
• 12.10. FERTIPRO NV
• 12.11. The Baker Company
• 12.12. BREG, Inc.

(*Note: SWOT analysis will be provided for the top 5 companies.)

13. Appendix

• 13.1. Available Customization
• 13.2. Related Reports